Curis Inc CRIS

NAS: CRIS | ISIN: US2312692005   30/04/2025
2,110 USD (+16,57%)
(+16,57%)   30/04/2025

29 april 2025 · Curis to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2025 · Persbericht

2 april 2025 · Curis to Present at Upcoming Healthcare Conference in April · Persbericht

31 maart 2025 · Curis Provides Fourth Quarter 2024 Business Update · Persbericht

28 maart 2025 · Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025 · Persbericht

4 september 2024 · Curis to Present at Upcoming Healthcare Conferences in September · Persbericht

1 augustus 2024 · Curis Provides Second Quarter 2024 Financial and Operating Update · Persbericht

25 juli 2024 · Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024 · Persbericht

10 juli 2024 · Curis to Present at Upcoming Healthcare Conference in July · Persbericht

8 juli 2024 · Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

14 mei 2024 · Curis Announces Additional Data from TakeAim Leukemia Study · Persbericht

10 mei 2024 · Curis to Present Updated Data from the TakeAim Leukemia Study · Persbericht

7 mei 2024 · Curis Provides First Quarter 2024 Business Update · Persbericht

30 april 2024 · Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024 · Persbericht

5 april 2024 · Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

4 april 2024 · Curis to Present at Upcoming Healthcare Conferences in April · Persbericht

8 februari 2024 · Curis Provides Fourth Quarter 2023 Business Update · Persbericht

1 februari 2024 · Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024 · Persbericht

5 januari 2024 · Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

12 december 2023 · Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study · Persbericht

11 december 2023 · Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference · Persbericht

Mijn selecties